A Lancet study has also shown that a single jab of this vaccine is 78.6-83.7% efficient against COVID-19, which is significantly better than the other two-shot vaccines.
The RDIF in the Webinar also announced the real-world data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine, demonstrating it is 80 per cent effective against coronavirus infection from 6 to 8 months after administering the second dose.
In Septemeber, the Drugs Controller General of India had granted permission for the conducting Phase 3 bridging trials of Sputnik Light on the Indian population.
Sputnik Light, the single-dose Covid-19 vaccine, can submit Russian safety data for approval in India, Dr Reddy's Laboratories said on Thursday.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.